201 related articles for article (PubMed ID: 36325681)
1. APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.
Britan-Rosich Y; Ma J; Kotler E; Hassan F; Botvinnik A; Smith Y; Moshel O; Nasereddin A; Sharma G; Pikarsky E; Ross S; Kotler M
FEBS J; 2023 Apr; 290(7):1822-1839. PubMed ID: 36325681
[TBL] [Abstract][Full Text] [Related]
2. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
3. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G rescues cells from the deleterious effects of DNA damage.
Botvinnik A; Shivam P; Smith Y; Sharma G; Olshevsky U; Moshel O; Manevitch Z; Climent N; Oliva H; Britan-Rosich E; Kotler M
FEBS J; 2021 Oct; 288(20):6063-6077. PubMed ID: 33999509
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair.
Nowarski R; Wilner OI; Cheshin O; Shahar OD; Kenig E; Baraz L; Britan-Rosich E; Nagler A; Harris RS; Goldberg M; Willner I; Kotler M
Blood; 2012 Jul; 120(2):366-75. PubMed ID: 22645179
[TBL] [Abstract][Full Text] [Related]
6. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
7. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
9. Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
Caswell D; Swanton C
Cancer Res; 2023 Feb; 83(4):487-488. PubMed ID: 36789568
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of APOBEC3G activity impedes double-stranded DNA repair.
Prabhu P; Shandilya SM; Britan-Rosich E; Nagler A; Schiffer CA; Kotler M
FEBS J; 2016 Jan; 283(1):112-29. PubMed ID: 26460502
[TBL] [Abstract][Full Text] [Related]
11. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
[TBL] [Abstract][Full Text] [Related]
12. Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.
Grant M; Larijani M
AIDS Res Ther; 2017 Sep; 14(1):44. PubMed ID: 28893290
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Antiviral Innate Immunity Through APOBEC Ribonucleoprotein Complexes.
Salter JD; Polevoda B; Bennett RP; Smith HC
Subcell Biochem; 2019; 93():193-219. PubMed ID: 31939152
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.
Talluri S; Samur MK; Buon L; Kumar S; Potluri LB; Shi J; Prabhala RH; Shammas MA; Munshi NC
Blood Cancer J; 2021 Oct; 11(10):166. PubMed ID: 34625538
[TBL] [Abstract][Full Text] [Related]
15. Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.
Monajemi M; Woodworth CF; Zipperlen K; Gallant M; Grant MD; Larijani M
PLoS One; 2014; 9(4):e93428. PubMed ID: 24722422
[TBL] [Abstract][Full Text] [Related]
16. Repair of APOBEC3G-Mutated Retroviral DNA
Salas-Briceno K; Ross SR
J Virol; 2021 Oct; 95(22):e0124421. PubMed ID: 34468176
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibition of HIV-1 Vif.
Nathans R; Cao H; Sharova N; Ali A; Sharkey M; Stranska R; Stevenson M; Rana TM
Nat Biotechnol; 2008 Oct; 26(10):1187-92. PubMed ID: 18806783
[TBL] [Abstract][Full Text] [Related]
19. B-cell agonists up-regulate AID and APOBEC3G deaminases, which induce IgA and IgG class antibodies and anti-viral function.
Seidl T; Whittall T; Babaahmady K; Lehner T
Immunology; 2012 Mar; 135(3):207-15. PubMed ID: 22044427
[TBL] [Abstract][Full Text] [Related]
20. The Enzymatic Activity of APOBE3G Multimers.
Pan Y; Zagorski K; Shlyakhtenko LS; Lyubchenko YL
Sci Rep; 2018 Dec; 8(1):17953. PubMed ID: 30560880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
